Researchers compared vaccine coadministration with single-dose, sequential vaccination for the RSVPreF3 OA vaccine formulation in adults.
|Articles|September 20, 2019
The Difference Between 503a and 503b Compounding Pharmacies
Loyd Allen, Editor in Chief of the International Journal of Pharmaceutical Compounding, discusses the roles and limitations of each respective compounding classification.
Advertisement
Loyd Allen, Editor in Chief of the International Journal of Pharmaceutical Compounding, discusses the roles and limitations of each respective compounding classification.
Advertisement
Related to this article
A study of women aged 50 to 69 years found that thrombotic risk varied by route of administration, estradiol dose, and duration of use.
Despite technology fostering a new generation of health care delivery, experts believe rural health solutions should be sought elsewhere.
Medicaid coverage of obesity-labeled GLP-1 receptor agonists may substitute for, rather than simply add to, diabetes-labeled use, a new study finds.
Researchers outline individual peripheral arterial disease burden as well as the most at-risk patient populations and treatment recommendations.
Availability will vary by state, and a pharmacy professor says cost barriers can keep families from getting vaccinated.
Darren Mensch, PharmD, BCPS, BCACP, provides evidence-based nuance regarding the emergence of mRNA vaccine technology and health care’s understanding of it.
Study findings tie continuous glucose monitoring measures to elevated cardiovascular risk in adults without diabetes.
Advertisement
Advertisement
Trending on Drug Topics
1
Normal vs. Concerning COVID-19 Vaccine Reactions: A Pharmacist's Guide
2
What Is HIV PrEP and Who Needs It Most?
3
Pharmacists Are Vital in Complex, Team-Based Treatment of PAD
4
Medicaid Coverage of Obesity GLP-1s May Shift From Diabetes Version
5